CMND
Clearmind Medicine Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.16
−31.76%1
Insider buys (3m)
4
Insider sells (3m)
$211.8K
Net value (3m)
-64.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 22,139 | $3.31 |
| Jun 17, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 3,183 | $3.32 |
| Jun 16, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 2,102 | $3.36 |
| Jun 12, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 2,159,052 | $0.15 |
| Jun 12, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 225,191 | $0.12 |
| May 16, 2017 | Lamadrid David · director, 10 percent owner, officer: CEO and President | A-Award | 857,143 | $0.35 |
Institutional positioning
13F filings over the trailing two quarters
New 3Increased 1Reduced 0Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| XTX TOPCO LTD | New Position | 21,694 | May 15, 2026 |
| HRT FINANCIAL LP | New Position | 15,910 | May 14, 2026 |
| ADVISORSHARES INVESTMENTS LLC | Increased | 7,357 | Apr 28, 2026 |
| ROYAL BANK OF CANADA | Unchanged | 14 | May 15, 2026 |
| UBS GROUP AG | New Position | 1 | May 5, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| AdvisorShares Investments LLC | Sold Out | 0 | Apr 28, 2026 |
| HRT FINANCIAL LP | Sold Out | 0 | May 14, 2026 |
| ROYAL BANK OF CANADA | Sold Out | 0 | May 15, 2026 |
| XTX Topco Ltd | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 18, 2026